ADR Flashcards

(70 cards)

1
Q

related to the pharmacological action of the drug

A

extension effects
detection: early in clinical development
dose dependent

ADR Type A - Augmented

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

not related to the pharmacological effect

A

side effects
ADR Type A - Augmented

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

oral hypoglycemics
hypoglycemia

A

extension effects
ADR Type A - Augmented

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

steroids
immunosuppression

A

extension effects
ADR Type A - Augmented

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

cns depressants (benzo/barbiturates)
sedation

A

extension effects
ADR Type A - Augmented

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

anticoagulants
bleeding

A

extension effects
ADR Type A - Augmented

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

antihypertensives
hypotension

A

extension effects
ADR Type A - Augmented

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

opiates
constipation

A

side effects
ADR Type A - Augmented

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

nitroglycerin
headache

A

side effects (vasodilated nerves in head)
ADR Type A - Augmented

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

ACEI
cough

A

side effects (bradykinin)
ADR Type A - Augmented

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

minoxidil
hirsutism

A

side effects
ADR Type A - Augmented

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

antihistamine
sedation

A

side effects (histamine = NT for wakefulness)
ADR Type A - Augmented

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

statins
rhabdomyolysis/hepatoxicity

A

side effects
ADR Type A - Augmented

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

aminoglycosides
nephro/oto/vestibulotoxicity

A

side effects
ADR Type A - Augmented

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

not pharmacologically predictable

A

bizarre
not dose dependent
detection: post-licensing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

genetically determined

A

idiosyncracy
ADR type B- Bizarre

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

malignant hyperthermia

A

caused by succinyl choline
DOC: dantrolene

idiosyncracy
ADR type B- Bizarre

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

hemolytic anemia

A

caused by G6PD deficiency and the ff
nsaids, sulfa drugs, soya/bean, camphor/menthol

idiosyncracy
ADR type B- Bizarre

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

stevens-johnson syndrome

A

caused by sulfa drugs
toxic epidermal necrolysis

idiosyncracy
ADR type B- Bizarre

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

determined by immune factors

A

ex asthma, dermatitis, allergic rhinitis, etc

hypersensitivity reactions
ADR type B - Bizarre

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

IgE mediated hypersensitivity

A

Type I - anaphylactic/immediate
b-cell mediated
DOC: epinephrine

symptoms: angioedema, urticaria, hives
low BP, bronchoconstriction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

food allergy

A

Type I - anaphylactic/immediate
b-cell (IgE) mediated

hypersensitivity reactions
ADR Type B - Bizarre

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

penicillin allergy

A

Type I - anaphylactic/immediate
b-cell (IgE) mediated

hypersensitivity reactions
ADR Type B - Bizarre

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

nsaids allergy

A

Type I - anaphylactic/immediate
b-cell (IgE) mediated

hypersensitivity reactions
ADR Type B - Bizarre

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
IgG mediated cytotoxic hypersensitivity
Type II - Cytotoxic b-cell (IgG, IgM) mediated hypersensitivity reactions ADR Type B - Bizarre
26
eryhtroblastosis fetalis
hemolytic disease of the newborn Rh incompatibility (+ & -) blood type DOC: Rhogam (Rh Ig) give: 28 weeks pregnant; 72 hrs after birth Type II - Cytotoxic b-cell (IgG, IgM) mediated hypersensitivity reactions ADR Type B - Bizarre
27
immune complex-mediated hypersensitivity
Type III - Immune complex-mediated b-cell mediated hypersensitivity reactions ADR Type B - Bizarre
28
rheumatoid arthritis
Type III - Immune complex-mediated b-cell mediated hypersensitivity reactions ADR Type B - Bizarre
29
systemic lupus erythematosus
Type III - Immune complex-mediated b-cell mediated hypersensitivity reactions ADR Type B - Bizarre
30
cell-mediated hypersensitivity
Type IV - Delayed/T cell mediated after 72 hrs hypersensitivity reactions ADR Type B - Bizarre
31
contact dermatitis
Type IV - Delayed/T cell mediated after 72 hrs hypersensitivity reactions ADR Type B - Bizarre
32
graft rejection
Type IV - Delayed/T cell mediated after 72 hrs hypersensitivity reactions ADR Type B - Bizarre
33
mantoux test
Type IV - Delayed/T cell mediated after 72 hrs hypersensitivity reactions ADR Type B - Bizarre
34
cumulative dose of the drug
ADR Type C - Continuous dose and time-related prolonged exposure
35
takes drug compulsively despite harm and desire to stop
addiction ADR Type C - Continuous
36
marijuana
addiction ADR Type C - Continuous
37
cocaine
addiction ADR Type C - Continuous
38
amphetamines
addiction ADR Type C - Continuous
39
LSD
addiction ADR Type C - Continuous
40
withdrawal effects w/out drug
dependence ADR Type C - Continuous
41
benzodiazepines
dependence ADR Type C - Continuous
42
caffeine
physiological dependence - body cant function well psychological dependence - mind cant function well dependence ADR Type C - Continuous
43
normal dose has less or no effect
tolerance/ tachyphylaxis ADR Type C - Continuous
44
nicotine
tolerance/ tachyphylaxis ADR Type C - Continuous
45
ability to cause caner/ neoplasm/ malignancy
carcinogenicity ADR Type D - Delayed
46
antineoplastic agents
carcinogenicity ADR Type D - Delayed
47
hydrocarbons
carcinogenicity ADR Type D - Delayed
48
aflatoxin
causes liver cancer carcinogenicity ADR Type D - Delayed
49
benzene
carcinogenicity ADR Type D - Delayed
50
PVC
carcinogenicity ADR Type D - Delayed
51
asbestos
causes lung cancer carcinogenicity ADR Type D - Delayed
52
ability to cause fetal malformations
teratogenicity ADR Type D - Delayed
53
neural tube defect
carbamazepine valproic acid teratogenicity ADR Type D - Delayed
54
vaginal adenocarcinoma
diethylstilbestrol teratogenicity ADR Type D - Delayed
55
fetal hydantoin syndrome
phenytoin teratogenicity ADR Type D - Delayed
56
phocomelia
thalidomide teratogenicity ADR Type D - Delayed
57
renal agenesis
ACEI/ARBS teratogenicity ADR Type D - Delayed
58
cleft lip, ear/eye defects, mental retardation
isotretinoin (must stop 3 months before pregnancy) teratogenicity ADR Type D - Delayed
59
withdrawal symptoms
ADR Type E - End of use remedy: taper dose
60
opiates irritability
ADR Type E - End of use
61
rebound insomnia & excitation
benzodiazepine ADR Type E - End of use
62
rebound hypertension
clonidine ADR Type E - End of use
63
rebound congestion
nasal decongestants
64
adrenal crisis
steroids
65
drug-drug interactions
ADR Type F - Failure of efficacy
66
use of counterfeit
ADR Type F - Failure of efficacy
67
drug instability
ADR Type F - Failure of efficacy
68
patient non compliance
ADR Type F - Failure of efficacy
69
wrong route of administration
ADR Type F - Failure of efficacy
70
drug resistance
ADR Type F - Failure of efficacy